Hirsch Douglas Joseph 4
4 · GoodRx Holdings, Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
Hirsch Douglas Joseph
Director
Transactions
- Conversion
Class B Common Stock
2024-06-01−126,552→ 0 total→ Class A Common Stock (126,552 underlying) - Conversion
Class A Common Stock
2024-06-01+126,552→ 5,265,442 total - Exercise/Conversion
Class B Common Stock
2024-06-01+256,594→ 256,594 total→ Class A Common Stock (256,594 underlying) - Tax Payment
Class B Common Stock
2024-06-01$7.87/sh−130,042$1,023,431→ 126,552 total→ Class A Common Stock (130,042 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-06-01−256,594→ 256,595 total→ Class B Common Stock (256,594 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class B common stock.
- [F2]The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020.
- [F3]Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027.